Clinical Trials at Bon Secours Cancer Institute at St. Francis
As of September 2026, 4 paid clinical trials are recruiting at Bon Secours Cancer Institute at St. Francis in Midlothian, Virginia. Active studies at this site cover conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8 and Breast Neoplasms. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
4 clinical trials at Bon Secours Cancer Institute at St. Francis
·Clear filters·Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
TERPS Trial for de Novo Oligometastic Prostate Cancer
Common conditions studied in Midlothian
- Breast Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Breast Neoplasms (4 active studies)
- Malignant Solid Neoplasm (3 active studies)
- Stage IVA Prostate Cancer AJCC v8 (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Midlothian
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- SWOG Cancer Research Network
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Midlothian?
There are approximately 51 recruiting clinical trials in Midlothian, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Midlothian pay participants?
Most recruiting trials in Midlothian compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Midlothian?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Midlothian?
The most common conditions under active study in Midlothian include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Breast Neoplasms (4), Malignant Solid Neoplasm (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Midlothian?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Midlothian on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Midlothian?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Midlothian?
Recruiting research sites in Midlothian include Bon Secours Saint Francis Medical Center, Bon Secours Westchester Emergency Center, Bon Secours Cancer Institute at St. Francis, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Midlothian right now?
The largest active categories in Midlothian are Cancer & tumors (37), Cardiovascular (2), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.